Literature DB >> 19634123

Simple and sensitive HPLC method for determination of amrubicin and amrubicinol in human plasma: application to a clinical pharmacokinetic study.

Reiko Ando1, Yoshinori Makino, Tomohide Tamura, Noboru Yamamoto, Rena Nishigaki, Takehiro Kimura, Nobuaki Yokote, Hiroshi Yamamoto.   

Abstract

A simple and sensitive high-performance liquid chromatographic (HPLC) method was developed for determination of amrubicin and its metabolite amrubicinol in human plasma. After protein precipitation with methanol without evaporation procedure, large volume samples were injected and separated by two monolithic columns with a guard column. The mobile phase consisted of tetrahydrofuran-dioxane-water (containing 2.3 mM acetic acid and 4 mM sodium 1-octanesulfonate; 2:6:15, v/v/v). Wavelengths of fluorescence detection were set at 480 nm for excitation and 550 nm for detection. Under these conditions, linearity was confirmed in the 2.5-5000 ng/mL concentration range of both compounds. The intra- and inter-day precision and intra- and inter-day accuracy for both compounds were less than 10%. The method was successfully applied to a clinical pharmacokinetic study of amrubicin and amrubicinol in cancer patients. 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19634123     DOI: 10.1002/bmc.1289

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  1 in total

1.  Individual optimal dose of amrubicin to prevent severe neutropenia in Japanese patients with lung cancer.

Authors:  Yoshinori Makino; Reiko Makihara-Ando; Takanori Ogawa; Hitoshi Sato; Yasushi Goto; Shintaro Kanda; Hidehito Horinouchi; Yutaka Fujiwara; Yuichiro Ohe; Noboru Yamamoto
Journal:  Cancer Sci       Date:  2019-10-03       Impact factor: 6.716

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.